Biocept (BIOC) Reports Q1 Loss of $0.25/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LYB
4. TFII
5. LITE
6. CL
7. RELIANCE:I
8. BP
9. ABBV
10. CVX

Go back to Biocept (BIOC) Reports Q1 Loss of $0.25/Share

Biocept Reports 2016 First Quarter Financial Results

May 12, 2016 4:06 PM EDT

SAN DIEGO, May 12, 2016 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a molecular diagnostics company commercializing and developing blood-based liquid biopsies to improve the diagnosis and treatment of cancer, reports financial results for the quarter ended March 31, 2016, and provides an update on business progress. 

"We are reporting a record 810 billable samples for the first quarter of 2016 and substantial progress on each of the... More